Johnson Health Tech .Co., Ltd. (TPE:1736)
Taiwan · Delayed Price · Currency is TWD 145.50
-2.50 (-1.69%)
Feb 2, 2026, 1:35 PM CST
Johnson Health Tech .Co. Income Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| 52,333 | 47,785 | 38,070 | 33,613 | 30,779 | 28,367 | |
Revenue Growth (YoY) | 21.34% | 25.52% | 13.26% | 9.21% | 8.51% | 11.80% |
Cost of Revenue | 25,478 | 23,507 | 19,642 | 19,007 | 16,873 | 14,969 |
Gross Profit | 26,855 | 24,278 | 18,427 | 14,606 | 13,906 | 13,397 |
Selling, General & Admin | 21,659 | 19,746 | 15,986 | 13,890 | 12,559 | 11,630 |
Research & Development | 1,128 | 1,147 | 1,062 | 913.22 | 808.65 | 785.54 |
Operating Expenses | 23,008 | 21,086 | 17,185 | 14,821 | 13,752 | 12,467 |
Operating Income | 3,847 | 3,192 | 1,242 | -214.93 | 154.19 | 930.09 |
Interest Expense | -350.82 | -349.8 | -377.47 | -256.18 | -163.48 | -163.23 |
Interest & Investment Income | 330.01 | 311.52 | 194.19 | 165.17 | 152.41 | 180.44 |
Currency Exchange Gain (Loss) | 192.67 | 330.82 | 363.44 | 970.59 | -96.88 | -265.71 |
Other Non Operating Income (Expenses) | 18.92 | 29.19 | -63.71 | -132.27 | 90.84 | 308.49 |
EBT Excluding Unusual Items | 4,037 | 3,514 | 1,359 | 532.38 | 137.08 | 990.07 |
Gain (Loss) on Sale of Investments | 4.68 | -14.89 | -15.23 | -226.39 | 23.18 | -6.8 |
Gain (Loss) on Sale of Assets | -10.69 | -6.32 | -9.05 | -2.38 | 3.44 | -7.94 |
Pretax Income | 4,031 | 3,492 | 1,334 | 303.61 | 163.7 | 975.33 |
Income Tax Expense | 1,193 | 1,062 | 625.05 | 78.67 | 64.33 | 227.98 |
Earnings From Continuing Operations | 2,838 | 2,431 | 709.44 | 224.94 | 99.37 | 747.35 |
Minority Interest in Earnings | -1.12 | -0.47 | 0.39 | 204.08 | -61.22 | -68.06 |
Net Income | 2,837 | 2,430 | 709.83 | 429.02 | 38.15 | 679.29 |
Net Income to Common | 2,837 | 2,430 | 709.83 | 429.02 | 38.15 | 679.29 |
Net Income Growth | 121.21% | 242.36% | 65.45% | 1024.63% | -94.38% | -47.45% |
Shares Outstanding (Basic) | 303 | 303 | 303 | 303 | 303 | 303 |
Shares Outstanding (Diluted) | 304 | 303 | 303 | 303 | 303 | 303 |
Shares Change (YoY) | 0.17% | 0.11% | 0.10% | 0.01% | -0.02% | -0.25% |
EPS (Basic) | 9.35 | 8.02 | 2.34 | 1.42 | 0.13 | 2.24 |
EPS (Diluted) | 9.33 | 8.01 | 2.34 | 1.42 | 0.13 | 2.24 |
EPS Growth | 120.71% | 242.31% | 65.06% | 1024.49% | -94.37% | -47.42% |
Free Cash Flow | 1,373 | 379.78 | 3,193 | -15.32 | -4,229 | 2,160 |
Free Cash Flow Per Share | 4.52 | 1.25 | 10.54 | -0.05 | -13.98 | 7.14 |
Dividend Per Share | 4.000 | 4.000 | 1.000 | 0.600 | 0.500 | 1.120 |
Dividend Growth | 300.00% | 300.00% | 66.67% | 20.00% | -55.36% | -20.00% |
Gross Margin | 51.31% | 50.81% | 48.40% | 43.45% | 45.18% | 47.23% |
Operating Margin | 7.35% | 6.68% | 3.26% | -0.64% | 0.50% | 3.28% |
Profit Margin | 5.42% | 5.09% | 1.86% | 1.28% | 0.12% | 2.40% |
Free Cash Flow Margin | 2.62% | 0.80% | 8.39% | -0.05% | -13.74% | 7.62% |
EBITDA | 4,499 | 3,852 | 1,812 | 323.24 | 637.49 | 1,318 |
EBITDA Margin | 8.60% | 8.06% | 4.76% | 0.96% | 2.07% | 4.64% |
D&A For EBITDA | 652.05 | 660.37 | 569.66 | 538.17 | 483.3 | 387.52 |
EBIT | 3,847 | 3,192 | 1,242 | -214.93 | 154.19 | 930.09 |
EBIT Margin | 7.35% | 6.68% | 3.26% | -0.64% | 0.50% | 3.28% |
Effective Tax Rate | 29.59% | 30.40% | 46.84% | 25.91% | 39.30% | 23.37% |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.